Inotiv, Inc. (NOTV)
NASDAQ: NOTV · Real-Time Price · USD
0.6310
-0.0168 (-2.59%)
At close: Dec 24, 2025, 1:00 PM EST
0.6480
+0.0170 (2.69%)
After-hours: Dec 24, 2025, 4:22 PM EST
Inotiv Revenue
In the fiscal year ending September 30, 2025, Inotiv had annual revenue of $513.02M with 4.54% growth. Inotiv had revenue of $138.14M in the quarter ending September 30, 2025, with 5.92% growth.
Revenue (ttm)
$513.02M
Revenue Growth
+4.54%
P/S Ratio
0.04
Revenue / Employee
$250,745
Employees
2,046
Market Cap
21.94M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 513.02M | 22.29M | 4.54% |
| Sep 30, 2024 | 490.74M | -81.69M | -14.27% |
| Sep 30, 2023 | 572.43M | 24.77M | 4.52% |
| Sep 30, 2022 | 547.66M | 458.05M | 511.19% |
| Sep 30, 2021 | 89.61M | -156.76M | -63.63% |
| Dec 31, 2020 | 246.37M | 185.90M | 307.43% |
| Sep 30, 2020 | 60.47M | 16.85M | 38.64% |
| Sep 30, 2019 | 43.62M | 17.27M | 65.55% |
| Sep 30, 2018 | 26.35M | 2.10M | 8.68% |
| Sep 30, 2017 | 24.24M | 3.80M | 18.59% |
| Sep 30, 2016 | 20.44M | -2.26M | -9.94% |
| Sep 30, 2015 | 22.70M | -1.89M | -7.67% |
| Sep 30, 2014 | 24.58M | 2.52M | 11.40% |
| Sep 30, 2013 | 22.07M | -6.14M | -21.77% |
| Sep 30, 2012 | 28.21M | -4.94M | -14.89% |
| Sep 30, 2011 | 33.14M | 4.36M | 15.16% |
| Sep 30, 2010 | 28.78M | -3.00M | -9.45% |
| Sep 30, 2009 | 31.78M | -9.91M | -23.77% |
| Sep 30, 2008 | 41.70M | 1.94M | 4.89% |
| Sep 30, 2007 | 39.75M | -3.30M | -7.65% |
| Sep 30, 2006 | 43.05M | 653.00K | 1.54% |
| Sep 30, 2005 | 42.40M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
NOTV News
- 13 days ago - Inotiv Partners with VUGENE to Advance AI-Driven Drug Discovery and Bioinformatics Capabilities - GlobeNewsWire
- 21 days ago - Inotiv, Inc. (NOTV) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 21 days ago - Inotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2025 and Provides Business Update - GlobeNewsWire
- 4 weeks ago - Inotiv Ranked Number 182nd Fastest-Growing Company in North America on the 2025 Deloitte Technology Fast 500™ - GlobeNewsWire
- 4 weeks ago - Inotiv, Inc. to Report Fiscal 2025 Fourth Quarter and Full Year Financial Results and Host Conference Call on Wednesday, December 3, 2025 - GlobeNewsWire
- 5 weeks ago - Top 3 Health Care Stocks Which Could Rescue Your Portfolio In November - Benzinga
- 5 weeks ago - Inotiv, Inc. Announces Preliminary Fiscal 2025 Fourth Quarter and Full Year Results - GlobeNewsWire
- 2 months ago - Halper Sadeh LLC Encourages Inotiv, Inc. Shareholders to Contact the Firm to Discuss Their Rights - Business Wire